{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-048043","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2026-07-13T20:38:21+00:00","discovered_at":"2026-07-13T20:39:00.357189+00:00","generated_at":"2026-07-13T20:39:07.275855+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sanuwave Health reports preliminary Q2 revenue $9.6-$9.8M, above guidance but down 3-5% YoY","bullets":["Preliminary Q2 2026 revenue of $9.6M-$9.8M, above revised guidance of $8.5M-$9.5M but down ~3-5% from $10.1M in Q2 2025.","Consumable applicator sales set all-time records for both unit sales and revenue, indicating growing Ultramist adoption.","Capital sales faced headwinds from customer stress and used Ultramist systems; trade-in program for certified pre-owned units showing success.","Results are preliminary and subject to adjustment upon completion of quarter-end close and review procedures."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-048043","json":"https://secwatch.observer/filing/0001628280-26-048043.json","markdown":"https://secwatch.observer/filing/0001628280-26-048043.md","text":"https://secwatch.observer/filing/0001628280-26-048043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/0001628280-26-048043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/snwv-20260713.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-13T20:39:07.275855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}